These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 11900228

  • 1. Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
    Miwa S, Miyagawa S, Soeda J, Kawasaki S.
    Cancer; 2002 Jan 15; 94(2):428-34. PubMed ID: 11900228
    [Abstract] [Full Text] [Related]

  • 2. Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma.
    Miwa S, Soeda J, Miyagawa S.
    Hepatogastroenterology; 2005 Jan 15; 52(65):1398-402. PubMed ID: 16201082
    [Abstract] [Full Text] [Related]

  • 3. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H.
    Hepatogastroenterology; 2002 Jan 15; 49(44):326-9. PubMed ID: 11995443
    [Abstract] [Full Text] [Related]

  • 4. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK, Paik YH, Park JY, Park KH, Bang S, Park SW, Chung JB, Park YN, Song SY.
    Am J Clin Oncol; 2006 Apr 15; 29(2):138-42. PubMed ID: 16601431
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.
    Hum Pathol; 2008 May 15; 39(5):710-9. PubMed ID: 18329694
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
    Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K.
    Clin Cancer Res; 2000 Mar 15; 6(3):1169-74. PubMed ID: 10741748
    [Abstract] [Full Text] [Related]

  • 7. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.
    Am J Clin Oncol; 2008 Feb 15; 31(1):55-63. PubMed ID: 18376229
    [Abstract] [Full Text] [Related]

  • 8. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.
    Carcinogenesis; 2004 Dec 15; 25(12):2353-60. PubMed ID: 15333466
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.
    Hepatogastroenterology; 2002 Dec 15; 49(44):311-6. PubMed ID: 11995440
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, Ikeda H, Sasaki M, Nimura Y, Nakanuma Y.
    Liver Int; 2007 Nov 15; 27(9):1174-84. PubMed ID: 17919228
    [Abstract] [Full Text] [Related]

  • 11. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar 15; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP, Shen GH, Ko JL.
    Lung Cancer; 2006 Jun 15; 52(3):349-57. PubMed ID: 16569461
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL.
    Lung Cancer; 2007 Dec 15; 58(3):384-91. PubMed ID: 17728005
    [Abstract] [Full Text] [Related]

  • 14. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
    Huang YC, Chen M, Shyr YM, Su CH, Chen CK, Li AF, Ho DM, Chen YM.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1384-9. PubMed ID: 18624901
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H.
    Clin Cancer Res; 2006 Dec 01; 12(23):6998-7003. PubMed ID: 17145820
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.
    J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS, Shu WP, Cohen AM, Guillem JG.
    Clin Cancer Res; 2002 Jan 01; 8(1):144-8. PubMed ID: 11801551
    [Abstract] [Full Text] [Related]

  • 18. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.
    Hepatogastroenterology; 2007 Mar 01; 54(74):346-9. PubMed ID: 17523271
    [Abstract] [Full Text] [Related]

  • 19. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K.
    Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618
    [Abstract] [Full Text] [Related]

  • 20. The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.
    Xiao M, Zhou NX, Huang ZQ, Lu YL, Chen LH, Wang DJ, Chang WL.
    Hepatobiliary Pancreat Dis Int; 2004 Nov 15; 3(4):599-602. PubMed ID: 15567754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.